Abhimanyu Sud is with the Department of Family and Community Medicine and Institute for Health Policy, Management, and Evaluation, University of Toronto, Canada. Daniel Z. Buchman is with Centre for Addiction and Mental Health and Dalla Lana School of Public Health, Toronto. Andrea D. Furlan is with the Institute for Work and Health and Department of Medicine, University of Toronto. Peter Selby is with the Centre for Addiction and Mental Health and Department of Family and Community Medicine, Department of Psychiatry, University of Toronto. Sheryl M. Spithoff is with Department of Family and Community Medicine, University of Toronto. Ross E. G. Upshur is with the Bridgepoint Collaboratory for Research and Innovation, Department of Family and Community Medicine, Dalla Lana School of Public Health, University of Toronto.
Am J Public Health. 2022 Feb;112(S1):S56-S65. doi: 10.2105/AJPH.2021.306500.
Clinically focused interventions for people living with pain, such as health professional education, clinical decision support systems, prescription drug monitoring programs, and multidisciplinary care to support opioid tapering, have all been promoted as important solutions to the North American opioid crisis. Yet none have so far delivered substantive beneficial opioid-related population health outcomes. In fact, while total opioid prescribing has leveled off or reduced in many jurisdictions, population-level harms from opioids have continued to increase dramatically. We attribute this failure partly to a poor recognition of the epistemic and ethical complexities at the interface of clinical and population health. We draw on a framework of knowledge networks in wicked problems to identify 3 strategies to help navigate these complexities: (1) designing and evaluating clinically focused interventions as complex interventions, (2) reformulating evidence to make population health dynamics apparent, and (3) appealing to the inseparability of facts and values to support decision-making in uncertainty. We advocate that applying these strategies will better equip clinically focused interventions as complements to structural and public health interventions to achieve the desired beneficial population health effects. (. 2022;112(S1):S56-S65. https://doi.org/10.2105/AJPH.2021.306500).
以患者为中心的干预措施,如卫生专业人员教育、临床决策支持系统、处方药物监测计划和多学科护理以支持阿片类药物逐渐减量,都被宣传为解决北美阿片类药物危机的重要方法。然而,到目前为止,这些方法都没有带来实质性的有益的阿片类药物相关人群健康结果。事实上,尽管在许多司法管辖区,阿片类药物的总处方量已经稳定或减少,但人群中阿片类药物造成的伤害仍在继续急剧增加。我们将这种失败部分归因于对临床和人群健康之间的认识论和伦理复杂性认识不足。我们借鉴复杂问题知识网络框架,确定了 3 种策略来帮助应对这些复杂性:(1)将以患者为中心的干预措施设计和评估为复杂干预措施,(2)重新构建证据,以明显体现人群健康动态,(3)呼吁事实和价值观的不可分割性,以支持不确定性下的决策。我们主张,应用这些策略将更好地使以患者为中心的干预措施成为结构和公共卫生干预措施的补充,以实现预期的有益的人群健康效果。(. 2022;112(S1):S56-S65。https://doi.org/10.2105/AJPH.2021.306500)。